Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 2.34% today. In the last week its performance is -0.44%, and -2.04% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 71.28, so today’s gain of 2.34% is a significant step towards its target price. The GAP today is therefore 0.80%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 101869.56, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 70.10%.
At the current price of 61.55, it has a dividend yield of 3.70%, and its target price is 71.28. This is with a profit margin of 23.10%, and total debt/equity of 6.71. AbbVie Inc. (NYSE:ABBV) has a P/E of 17.65, as well as a forward P/E of 10.91.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 17.41%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 15.95%.
Performance for the year is 13.83%. Since its IPO date on 1/2/2013, the total performance to date is 7.92%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 6633400, while its average volume is 6260.21. Whilst the total gain today was 2.34%, it did have a day high of -8.81%.
Volatility for this week has been at 1.85%, and 1.59% for the month. The 52-week low for AbbVie Inc., ABBV has been 40.66%, while the 52-week-high has reached -8.81%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.00%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.62, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.11, and the P/S is 4.12, along with a P/B of 17.74. Meanwhile it has a p/cash of 12.73.